$551.5 M

PACB Mkt cap, 15-Oct-2018

$40.9 M

Pacific Biosciences of California Revenue Q2, 2018
Pacific Biosciences of California Gross profit (Q2, 2018)16.2 M
Pacific Biosciences of California Gross profit margin (Q2, 2018), %39.5%
Pacific Biosciences of California Net income (Q2, 2018)-46.7 M
Pacific Biosciences of California EBIT (Q2, 2018)-45.7 M
Pacific Biosciences of California Cash, 30-Jun-201823.1 M

Pacific Biosciences of California Revenue

Pacific Biosciences of California revenue was $93.47 m in FY, 2017

Embed Graph

Pacific Biosciences of California Revenue Breakdown

Embed Graph

Pacific Biosciences of California revenue breakdown by geographic segment: 21.9% from Asia, 22.1% from Europe and 56.0% from North America

Pacific Biosciences of California Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

28.2m60.6m92.8m90.7m93.5m

Revenue growth, %

115%53%(2%)

Cost of goods sold

21.8m37.2m39.3m46.6m58.8m

Gross profit

6.4m23.4m53.5m44.2m34.7m

Gross profit Margin, %

23%39%58%49%37%

R&D expense

67.6m65.3m

General and administrative expense

59.1m

Operating expense total

67.6m124.4m

EBIT

(77.5m)(62.9m)(29.1m)(71.2m)(89.8m)

EBIT margin, %

(275%)(104%)(31%)(79%)(96%)

Interest expense

2.5m2.8m2.9m3.2m2.9m

Net Income

(79.3m)(66.2m)(31.7m)(74.4m)(92.2m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Revenue

7.4m11.6m11.4m20.6m17.6m24.9m13.9m19.1m20.7m25.1m24.9m20.1m19.4m40.9m

Cost of goods sold

6.2m9.0m8.3m7.5m11.7m10.4m7.4m9.6m10.1m12.5m16.0m12.1m12.1m24.8m

Gross profit

1.2m2.7m3.1m13.2m5.9m14.5m6.6m9.5m10.6m12.6m8.9m8.0m7.3m16.2m

Gross profit Margin, %

17%23%27%64%34%58%47%50%51%50%36%40%38%39%

R&D expense

10.4m11.8m12.4m11.7m14.5m15.0m16.2m16.4m17.5m17.5m17.0m16.9m16.3m32.0m

General and administrative expense

14.9m29.9m

Operating expense total

21.2m20.9m21.4m21.6m25.3m25.9m3.9m28.1m28.7m29.4m32.2m32.4m31.2m61.9m

EBIT

(19.9m)(18.2m)(18.3m)(8.4m)(19.3m)(11.4m)(18.6m)(18.1m)(16.7m)(23.3m)(24.4m)(23.9m)(45.7m)

EBIT margin, %

(269%)(157%)(160%)(41%)(110%)(46%)(97%)(87%)(67%)(94%)(121%)(124%)(112%)

Interest expense

686.0k686.0k701.0k716.0k697.0k715.0k741.0k779.0k795.0k821.0k838.0k826.0k581.0k1.2m

Net Income

(20.5m)(18.9m)(19.1m)(9.2m)(20.2m)(11.9m)1.8m(19.4m)(18.5m)(17.5m)(23.9m)(25.5m)(24.2m)(46.7m)

Pacific Biosciences of California Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

26.4m36.4m33.6m16.8m16.5m

Accounts Receivable

2.7m3.4m5.2m11.4m13.4m

Inventories

1.1m1.7m12.1m15.6m23.1m

Current Assets

126.5m117.8m110.5m109.0m101.6m

PP&E

9.2m6.6m8.5m14.6m37.9m

Total Assets

136.2m124.5m131.1m137.9m144.1m

Accounts Payable

1.7m5.6m4.7m8.4m9.1m

Short-term debt

14.1m14.9m16.1m

Current Liabilities

22.6m31.5m38.2m33.8m28.6m

Long-term debt

14.1m14.9m16.1m

Total Debt

28.2m29.9m32.2m

Total Liabilities

53.2m58.0m

Additional Paid-in Capital

684.4m736.3m786.6m872.1m965.8m

Retained Earnings

(615.3m)(681.5m)(713.2m)(787.5m)(879.7m)

Total Equity

69.2m54.9m73.5m84.7m86.1m

Debt to Equity Ratio

0.5 x0.4 x0.4 x

Debt to Assets Ratio

0.2 x0.2 x0.2 x

Financial Leverage

2 x2.3 x1.8 x1.6 x1.7 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

Cash

64.8m41.3m28.2m35.4m30.3m25.9m27.2m20.1m24.8m22.8m29.0m36.5m25.5m23.1m

Accounts Receivable

3.8m3.4m4.3m2.4m5.3m4.0m4.2m8.0m10.4m11.8m10.4m9.5m8.5m7.4m

Inventories

9.8m8.3m9.4m11.4m13.5m12.0m11.6m12.2m14.2m16.5m15.3m17.3m25.9m23.4m

Current Assets

141.8m132.1m119.9m114.1m99.5m90.2m86.2m119.1m138.1m122.5m88.3m132.9m115.7m96.4m

PP&E

10.5m8.5m7.9m7.0m6.7m6.4m7.9m9.1m11.2m14.0m42.4m40.3m36.7m36.1m

Total Assets

152.8m141.0m128.2m121.6m106.4m96.8m99.8m140.2m161.4m150.6m135.5m177.9m156.9m137.1m

Accounts Payable

3.4m3.9m5.4m5.8m6.9m5.8m6.1m4.7m5.4m8.3m8.2m6.5m8.6m4.2m

Short-term debt

13.2m13.5m13.7m13.9m14.3m14.6m14.8m15.2m15.5m15.8m

Current Liabilities

22.5m22.5m28.0m29.1m38.4m39.0m38.8m32.0m33.8m32.1m35.4m35.7m24.9m22.3m

Long-term debt

13.2m13.5m13.7m13.9m14.3m14.6m14.8m15.2m15.5m15.8m

Total Debt

26.3m27.1m27.4m27.8m28.7m29.1m29.6m30.4m31.0m31.6m

Total Liabilities

69.3m65.5m69.2m68.6m65.9m62.9m58.4m51.4m53.3m52.0m66.3m62.0m54.2m51.6m

Additional Paid-in Capital

709.6m712.2m715.4m742.0m747.3m753.0m821.2m858.9m867.1m880.5m952.7m1.0b1.0b

Retained Earnings

(598.1m)(634.2m)(653.3m)(662.5m)(701.6m)(713.6m)(711.8m)(732.5m)(751.0m)(768.5m)(811.4m)(836.9m)(903.7m)(926.3m)

Total Equity

83.5m75.5m59.0m53.0m40.5m33.8m41.4m88.8m108.1m98.7m69.2m115.9m102.7m85.5m

Financial Leverage

1.8 x1.9 x2.2 x2.3 x2.6 x2.9 x2.4 x1.6 x1.5 x1.5 x2 x1.5 x1.5 x1.6 x

Pacific Biosciences of California Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(79.3m)(66.2m)(31.7m)(74.4m)(92.2m)wdxefcqufszuzezftuxetqsqxt

Depreciation and Amortization

5.6m4.2m3.7m3.9m8.4m

Accounts Receivable

76.0k(660.0k)(1.7m)(6.2m)(2.0m)

Inventories

(60.0k)(1.3m)(2.5m)(6.2m)(8.4m)

Accounts Payable

(1.3m)3.9m(716.0k)3.4m764.0k

Cash From Operating Activities

(29.8m)(51.5m)(47.9m)(67.9m)(67.5m)

Purchases of PP&E

(909.0k)(1.6m)(3.0m)(8.2m)(10.4m)

Cash From Investing Activities

(33.1m)19.6m8.6m(14.9m)(1.5m)

Cash From Financing Activities

42.8m42.0m36.5m65.9m68.8m

Interest Paid

1.2m1.8m1.8m1.8m1.7m

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

Net Income

(20.5m)(18.9m)(19.1m)(9.2m)(20.2m)(11.9m)1.8m(19.4m)(18.5m)(17.5m)(23.9m)(24.2m)(46.7m)

Depreciation and Amortization

1.8m3.6m

Accounts Receivable

4.3m2.4m5.3m4.0m4.2m8.0m10.4m11.8m10.4m5.0m6.0m

Inventories

13.5m12.0m11.6m12.2m14.2m16.5m15.3m(2.7m)(560.0k)

Accounts Payable

5.4m5.8m6.9m5.8m6.1m4.7m5.4m8.3m8.2m(942.0k)(4.8m)

Cash From Operating Activities

(18.8m)(33.3m)

Purchases of PP&E

(344.0k)(1.7m)

Cash From Investing Activities

(7.7m)4.4m

Cash From Financing Activities

35.5m35.4m

Pacific Biosciences of California Ratios

USDY, 2018

Financial Leverage

1.6 x
Report incorrect company information

Pacific Biosciences of California Operating Metrics

FY, 2016

Patents (US)

221

Patents (foreign)

133

Patents Pending

187
Report incorrect company information